Clinical and molecular characterization of SLC31A1-related developmental and epileptic encephalopathy: insights from 13 new cases
Copper is indispensable for various metabolic processes, notably mitochondrial respiration. In humans, copper homeostasis hinges on transporters such as copper transporter 1 (CTR1), encoded by the <i>SLC31A1</i> gene. Recently, bi-allelic mutations in <i>SLC31A1</i> have been associated with a new neurodevelopmental disorder. This study presents clinical, genetic, and biochemical findings from 13 new cases across 10 families worldwide. RNA sequencing evaluated gene expression, and Western blotting assessed copper transporter 1 protein levels. Additionally, mitochondrial respiratory capacity was measured via high-resolution respirometry. Affected individuals exhibited a distinct clinical phenotype characterized by early-onset epileptic encephalopathy, severe neurodevelopmental delay and hypotonia, with high mortality. Neuroimaging revealed significant brain atrophy and white matter abnormalities. Genetic analysis identified bi-allelic <i>SLC31A1</i> variants, predominantly p.His120Gln in six cases and p.(Arg102Cys/His) in three cases. Functional studies in patient fibroblasts demonstrated impaired mitochondrial respiration. This study significantly broadens the clinical spectrum of this recently described syndrome, presenting as a severe developmental encephalopathy with high mortality risk, and suggests mitochondrial dysfunction as a potential pathomechanism. These findings contribute to the mounting evidence linking copper transporter 1 dysfunction to neurodegeneration, underscoring the urgency for further therapeutic investigations.
Authors
- Afshin Fayazi (ORCID: https://orcid.org/0000-0002-4625-2014)
- Marta Gómez‐Chiari (ORCID: https://orcid.org/0000-0001-6726-1721)
- Christopher J. Carroll (ORCID: https://orcid.org/0000-0002-2814-6955)
- Mar O’Callaghan (ORCID: https://orcid.org/0000-0002-1896-1622)
- Klaas J. Wierenga (ORCID: https://orcid.org/0000-0002-6623-3881)
- Jordi Muchart-López
- Janet Hoenicka (ORCID: https://orcid.org/0000-0002-6790-6988)
- Natalia Juliá‐Palacios (ORCID: https://orcid.org/0000-0002-2560-3970)
- Ingrid Cristian
- Rafael Artuch (ORCID: https://orcid.org/0000-0002-3422-9685)
- Seyed Hassan Tonekaboni (ORCID: https://orcid.org/0000-0003-0853-8465)
- Frederic Tort (ORCID: https://orcid.org/0000-0003-2733-1603)
- Huma Arshad Cheema (ORCID: https://orcid.org/0000-0002-0463-687X)
- Gerard Muñoz‐Pujol (ORCID: https://orcid.org/0000-0002-6863-3993)
- Roser Urreizti (ORCID: https://orcid.org/0000-0003-3617-7134)
- Patrick M. Gaffney (ORCID: https://orcid.org/0000-0002-1580-869X)
- Abraham J. Paredes‐Fuentes (ORCID: https://orcid.org/0000-0002-7163-2385)
- Bryn D. Webb (ORCID: https://orcid.org/0000-0001-6174-4677)
- Juan Darío Ortigoza‐Escobar (ORCID: https://orcid.org/0000-0002-6320-2641)
- Irene Machado-Casas
- Marwa Abd Elmaksoud (ORCID: https://orcid.org/0000-0001-5827-4459)
- Jennifer Morrison
- Nouriya Al‐Sannaa (ORCID: https://orcid.org/0000-0002-0828-7443)
- Àngels García‐Cazorla (ORCID: https://orcid.org/0000-0001-9853-688X)
- Antònia Ribes (ORCID: https://orcid.org/0000-0002-2249-246X)
- Aida M. Bertoli‐Avella (ORCID: https://orcid.org/0000-0001-9544-1877)
- Mohammad Miryounesi (ORCID: https://orcid.org/0000-0003-4705-3794)
- Henry Houlden (ORCID: https://orcid.org/0000-0002-2866-7777)
- Reza Maroofian (ORCID: https://orcid.org/0000-0001-6763-1542)
- Carlos Santos‐Ocaña (ORCID: https://orcid.org/0000-0002-2379-796X)
- Francesc Palau (ORCID: https://orcid.org/0000-0002-8635-5421)
- Heidy Baide‐Mairena (ORCID: https://orcid.org/0000-0003-2558-7867)
- Sahar Alijanpour (ORCID: https://orcid.org/0000-0003-0734-6787)
- Emir Zonic
- Peter Bauer
- Muhammad Nadeem Anjum
- Anna Codina (ORCID: https://orcid.org/0000-0003-0673-9087)
- Faroug Ababneh
- Mary W. Tyler
- Maria Urbaniak
- Uxía Barba
Institutions
- Hamedan University of Medical Sciences (IR)
- Hospital Sant Joan de Déu Barcelona (ES)
- University of Wisconsin–Madison (US)
- St George's, University of London (GB)
- King Saud bin Abdulaziz University for Health Sciences (SA)
- Lahore General Hospital (PK)
- Arnold Palmer Hospital for Children (US)
- Saudi Aramco Medical Services Organization (SA)
- King Abdulaziz Medical City (SA)
- Oklahoma Medical Research Foundation (US)
- University of Florida (US)
- Jahrom University of Medical Sciences (IR)
- Hospital General de Granollers (ES)
- Centro Andaluz de Biología del Desarrollo (ES)
- Instituto de Investigación Biosanitaria de Granada (ES)
- Hospital Clínic de Barcelona (ES)
- Synaptic Research (United States) (US)
- King Abdulaziz Hospital (SA)
- Centogene (Germany) (DE)
- Genomics England (GB)
- Mayo Hospital (PK)
- National Hospital for Neurology and Neurosurgery (GB)
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- Instituto de Investigación de Enfermedades Raras (ES)
- University College London (GB)
- Shahid Beheshti University of Medical Sciences (IR)
- Alexandria University (EG)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Brain Communications
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1093/braincomms/fcaf348
- Citations
- 2
- Primary Topic
- Trace Elements in Health
- Type
- article
- Field-Weighted Citation Impact
- 2.24
Funders
- Centres de Recerca de Catalunya
- European Commission
- Generalitat de Catalunya
- Universitat de Barcelona
- Asociación de Enfermos de Patologías Mitocondriales
- Agència de Gestió d'Ajuts Universitaris i de Recerca
- Instituto de Salud Carlos III